Solventum US
United States Updated 9 July 2026
Solventum US is a finished-dose manufacturer based in United States. It holds one valid CEP. Its filings concentrate with Health Canada, US FDA and EMA. Its GMP standing is certified by ZLG (DE), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as VAI.
4
registered plants
2 with an FDA FEI number
16
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 6 September 2024 VAI US FDA
- 4 February 2016 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Kamen, Germany | Not on file |
| Seefeld, Germany | Not on file |
| Eagan, United States | 3042272797 |
| Columbia, United States | 3003399824 |
What they file, and where
| Molecule | Regulators | Docs |
| Collagen | EDQM | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| Health Canada | 9 | None |
| US FDA | 5 | 1 |
| EMA | 2 | 1 |
| ZLG (DE) | None | 4 |
Comparing suppliers?
Choose your molecules and target markets. Solventum US comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 6 September 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates